Lupin Recalls Liraglutide Injection Over Particulate Matter Found in Cartridge
FDA’s enforcement listings show a Class II recall (D-0541-2026) by Lupin Pharmaceuticals Inc. of Liraglutide Injection, 18 mg/3 mL (6 mg/mL), a prescription product. The stated reason is "Presence of particulate matter: a white thread-like structure in the cartridge." The recall is dated May 27, 2026 and its status is listed as ongoing.
What this meansRecalls happen in the approved supply chain too — if you use liraglutide, comparing your lot number against FDA’s recall listing is a quick, worthwhile check.
Source: FDA original ↗